NDAORALCAPSULE
Approved
Aug 1946
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 44m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FOLVRON is an oral capsule combination of ferrous sulfate and folic acid, indicated for iron and folate deficiency anemia. It is an adjunctive nutritional supplement that replenishes both iron stores and folate cofactors essential for red blood cell formation. The product works through iron absorption in the GI tract and folate-mediated one-carbon metabolism.
LOE Approaching
This legacy product approaching loss of exclusivity faces moderate competitive pressure (30%), suggesting a contracting brand team focused on retention and cost management rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FOLVRON offers limited career growth opportunity given its mature lifecycle and approaching LOE; roles are primarily defensive, focused on protecting market share against generics and optimizing profitability. This assignment suits mid-career professionals seeking stable, lower-intensity work rather than high-visibility launches or expansion.
Brand ManagerAccount Manager
Worked on FOLVRON at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.